Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Physics in Medicine and Biology
|
September 18, 2018
Cone-beam CT reconstruction with gravity-induced motion
Chun-Chien Shieh, Jeffrey Barber, William Counter, et al.
Physics in Medicine and Biology
|
April 19, 2018
A CBCT study of the gravity-induced movement in rotating rabbits
Jeffrey Barber, Chun-Chien Shieh, William Counter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 22, 2023
The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy
Shejil Kumar, Megan Crumbaker, Christopher Harvey, et al.
Advances in Radiation Oncology
|
July 26, 2017
Functional imaging equivalence and proof of concept for image-guided adaptive radiotherapy with fixed gantry and rotating couch
Ilana Feain, Chun-Chien Shieh, Paul White, et al.
BJU International
|
November 13, 2022
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer
Paul Doan, William Counter, Nathan Papa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 10, 2022
<sup>177</sup>Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing <sup>177</sup>Lu-PSMA-I&T Therapy
Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CT
Sherrington Li, Andrew Nguyen, William Counter, et al.
Therapeutic Advances in Medical Oncology
|
March 6, 2023
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)
Louise Emmett, Nikeith John, Sarennya Pathmanandavel, et al.
BJU International
|
October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy
Bart Geboers, Dennie Meijer, William Counter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database
Louise Emmett, Nathan Papa, William Counter, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Physics in Medicine and Biology
|
September 18, 2018
Cone-beam CT reconstruction with gravity-induced motion
Chun-Chien Shieh, Jeffrey Barber, William Counter, et al.
Physics in Medicine and Biology
|
April 19, 2018
A CBCT study of the gravity-induced movement in rotating rabbits
Jeffrey Barber, Chun-Chien Shieh, William Counter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 22, 2023
The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy
Shejil Kumar, Megan Crumbaker, Christopher Harvey, et al.
Advances in Radiation Oncology
|
July 26, 2017
Functional imaging equivalence and proof of concept for image-guided adaptive radiotherapy with fixed gantry and rotating couch
Ilana Feain, Chun-Chien Shieh, Paul White, et al.
BJU International
|
November 13, 2022
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer
Paul Doan, William Counter, Nathan Papa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 10, 2022
<sup>177</sup>Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing <sup>177</sup>Lu-PSMA-I&T Therapy
Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CT
Sherrington Li, Andrew Nguyen, William Counter, et al.
Therapeutic Advances in Medical Oncology
|
March 6, 2023
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)
Louise Emmett, Nikeith John, Sarennya Pathmanandavel, et al.
BJU International
|
October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy
Bart Geboers, Dennie Meijer, William Counter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database
Louise Emmett, Nathan Papa, William Counter, et al.
Page
of 2